2.43
price up icon3.85%   0.09
pre-market  Pre-mercato:  2.45   0.02   +0.82%
loading

Taysha Gene Therapies Inc Borsa (TSHA) Ultime notizie

pulisher
Jun 14, 2025

Taysha Gene Therapies’ SWOT analysis: promising Rett syndrome therapy boosts stock outlook - Investing.com Australia

Jun 14, 2025
pulisher
Jun 13, 2025

Taysha Gene Therapies price target maintained at $13 by Cantor Fitzgerald - Investing.com Canada

Jun 13, 2025
pulisher
Jun 12, 2025

Taysha gene therapies stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Jun 12, 2025
pulisher
Jun 11, 2025

Taysha Gene Therapies (TSHA) Price Target Raised Amid High Trial Success Confidence | TSHA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Adjusts Price Target on Taysha Gene Therapies to $13 From $7, Maintains Overweight Rating - MarketScreener

Jun 11, 2025
pulisher
Jun 10, 2025

Needham Reiterates Buy Rating for Taysha Gene Therapies (TSHA) | - GuruFocus

Jun 10, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Signify Bio’s $15M round advances in situ protein therapeutics - BioWorld MedTech

Jun 06, 2025
pulisher
Jun 06, 2025

Kalkine: Taysha Gene Therapies Grants Equity Awards to New Joiners – A Closer Look at FTSE 350 Companies' Global Peers - Kalkine Media

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | TSHA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies (TSHA) Grants Stock Options to New Employees | TSHA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies Grants Stock Options to New Employees Under Inducement Plan - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

Gene Therapy Leader Taysha Awards Massive 401K Share Options Package to Key New Executives - Stock Titan

Jun 06, 2025
pulisher
Jun 05, 2025

Finance Watch: Vera Raises Debt, Taysha And Trevi Price Offering After Big Trial Wins - insights.citeline.com

Jun 05, 2025
pulisher
Jun 05, 2025

Taysha Gene Therapies Stock (TSHA): Innovative Gene Therapy Focus - Value The Markets

Jun 05, 2025
pulisher
Jun 04, 2025

Taysha Gene Therapies Releases TSHA-102 Clinical Program Updates - Insider Monkey

Jun 04, 2025
pulisher
Jun 04, 2025

Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Purchased by ProShare Advisors LLC - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Acquires New Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Jane Street Group LLC Acquires 62,003 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Given New $11.00 Price Target at Canaccord Genuity Group - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Taysha reports progress in Rett syndrome gene therapy trials By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data By Stocktwits - Investing.com India

Jun 03, 2025
pulisher
Jun 03, 2025

taysha gene therapies increases authorized shares to 700 million By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies (TSHA) Advances TSHA-102 Program for Rett - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details for Oral Presentations a - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha reports progress in Rett syndrome gene therapy trials - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program - The Manila Times

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details For Oral Presentations - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program | TSHA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details for Oral - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

Needham Lifts Taysha Gene Therapies (TSHA) PT to $8, Cites Positive Clinical Data - Insider Monkey

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies’ (TSHA) Buy Rating Reaffirmed at Needham & Company LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies (TSHA) Target Price Raised by Canaccord Ge - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies (TSHA) Price Target Raised by Canaccord | - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

taysha gene therapies increases authorized shares to 700 million - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Approves Share Increase Amendment - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies (TSHA) Price Target Raised by Canaccord | TSHA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

Positive Outlook for Taysha Gene Therapies: Buy Rating on Promising TSHA-102 Advancements - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Taysha Gene Therapies (TSHA) Updates Clinical Progress in Rett S - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Where Taysha Gene Therapies Stands With Analysts - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Needham Adjusts Taysha Gene Therapies Price Target to $8 From $6, Maintains Buy Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Taysha Gene Therapies (TSHA) Sees Increased Price Target by Needham | TSHA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Needham Increases Price Target for Taysha Gene Therapies (TSHA) to $8 | TSHA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Taysha Gene Therapies (TSHA) Price Target Raised by JMP on Positive Rett Syndrome Trial Data - MSN

Jun 02, 2025
pulisher
Jun 02, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Stake Lessened by Deutsche Bank AG - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Bank of America Corp DE Boosts Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 01, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):